Breaking News Instant updates and real-time market news.

REVG

REV Group

$17.83 /

-1.56 (-8.05%)

10:00
06/10/21
06/10
10:00
06/10/21
10:00

REV Group falls -8.5%

REV Group is down -8.5%, or -$1.66 to $17.75.

  • 11

    Jun

REVG REV Group
$17.83 /

-1.56 (-8.05%)

06/08/21 Baird
REV Group price target raised to $25 from $22 at Baird
06/08/21 Baird
REV Group demand and operating momentum still building, says Baird
03/12/21 BMO Capital
REV Group price target raised to $19 from $10 at BMO Capital
03/11/21 Morgan Stanley
REV Group price target raised to $18 from $10 at Morgan Stanley

TODAY'S FREE FLY STORIES

Recommendations
AlloVir remains a top small-cap pick at Piper Sandler » 04:58
06/14/21
06/14
04:58
06/14/21
04:58
ALVR

AlloVir

$22.07 /

+0.21 (+0.96%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/22/21 Piper Sandler
AlloVir remains a top 2021 pick at Piper Sandler
02/11/21 Piper Sandler
AlloVir price target raised to $55 from $52 at Piper Sandler
08/24/20 Piper Sandler
AlloVir initiated with an Overweight at Piper Sandler
ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

  • 30
    Jul
Recommendations
ViewRay shares should attract more investor interest, says Piper Sandler » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
VRAY

ViewRay

$5.80 /

+0.05 (+0.87%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

Conference/Events
Cornerstone OnDemand participates in a conference call with Benchmark » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
CSOD

Cornerstone OnDemand

$50.98 /

+0.08 (+0.16%)

Analyst Schappel holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
02/17/21 BMO Capital
Cornerstone OnDemand price target raised to $63 from $47 at BMO Capital
CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

Conference/Events
OncoCyte management to meet virtually with BTIG » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
OCX

OncoCyte

$5.45 /

+0.225 (+4.31%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

  • 05
    Feb
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

Conference/Events
Gain Therapeutics management to meet virtually with Oppenheimer » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
GANX

Gain Therapeutics

$10.13 /

-0.02 (-0.20%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 BTIG
Gain Therapeutics initiated with a Buy at BTIG
  • 18
    Mar
GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

Conference/Events
Snowflake management to meet virtually with Oppenheimer » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
SNOW

Snowflake

$240.83 /

-7.96 (-3.20%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

06/11/21 Morgan Stanley
Morgan Stanley says 'unprecedented' Snowflake forecast may still be conservative
06/11/21 JMP Securities
Snowflake target model calls for $10B in revenue by FY29, says JMP Securities
06/11/21 Piper Sandler
Snowflake price target lowered to $290 from $312 at Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

  • 16
    Mar
  • 16
    Sep
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Retail/Broadlines &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley Securities
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

  • 15
    Dec
  • 11
    Dec
  • 09
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Conference/Events
Jefferies aerospace/defense analysts to hold analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jefferies aerospace/defense analysts to hold analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BioVie management to meet virtually with B. Riley » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
BIVI

BioVie

$17.99 /

+3.09 (+20.74%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIVI BioVie
$17.99 /

+3.09 (+20.74%)

BIVI BioVie
$17.99 /

+3.09 (+20.74%)

05/25/21 B. Riley
BioVie price target raised to $50 from $47 at B. Riley
01/15/21 B. Riley Securities
B. Riley starts 'largely overlooked' BioVie with Buy, $47 target
01/15/21 B. Riley Securities
BioVie initiated with a Buy at B. Riley Securities
Conference/Events
Cantor biotech/biopharma analysts hold an analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Biotech Analyst Young and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Gracell to host conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
GRCL

Gracell

$14.35 /

+0.11 (+0.77%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRCL Gracell
$14.35 /

+0.11 (+0.77%)

GRCL Gracell
$14.35 /

+0.11 (+0.77%)

06/07/21 Citi
Gracell valuation provides attractive entry point, says Citi
06/04/21 Piper Sandler
Piper sees 'clear line of sight for value creation' at Gracell after ASCO
04/30/21 Piper Sandler
Gracell transferred with Overweight rating at Piper Sandler
02/03/21 Citi
Gracell initiated with a Buy at Citi
GRCL Gracell
$14.35 /

+0.11 (+0.77%)

  • 08
    Jan
GRCL Gracell
$14.35 /

+0.11 (+0.77%)

Conference/Events
E2open management to meet virtually with Loop Capital » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
ETWO

E2open

$13.37 /

-0.515 (-3.71%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETWO E2open
$13.37 /

-0.515 (-3.71%)

ETWO E2open
$13.37 /

-0.515 (-3.71%)

04/21/21 Loop Capital
E2open initiated with a Buy at Loop Capital
04/21/21 Loop Capital
E2open initiated with a Buy at Loop Capital
04/20/21 Loop Capital
E2open initiated with a Buy at Loop Capital
03/23/21 UBS
E2open initiated with a Neutral at UBS
ETWO E2open
$13.37 /

-0.515 (-3.71%)

ETWO E2open
$13.37 /

-0.515 (-3.71%)

ETWO E2open
$13.37 /

-0.515 (-3.71%)

Conference/Events
Clene participates in a conference call with Maxim » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
CLNN

Clene

$11.16 /

-0.29 (-2.53%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLNN Clene
$11.16 /

-0.29 (-2.53%)

CLNN Clene
$11.16 /

-0.29 (-2.53%)

05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/03/21 Cantor Fitzgerald
Clene initiated with an Overweight at Cantor Fitzgerald
03/29/21 Roth Capital
Clene to release results from four Phase 2 trials in 2H, says Roth Capital
CLNN Clene
$11.16 /

-0.29 (-2.53%)

Conference/Events
Quantum participates in a conference call with Northland » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
QMCO

Quantum

$7.54 /

+0.35 (+4.87%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QMCO Quantum
$7.54 /

+0.35 (+4.87%)

QMCO Quantum
$7.54 /

+0.35 (+4.87%)

03/05/21 Northland
Quantum initiated with an Outperform at Northland
03/03/21 Oppenheimer
Quantum initiated with an Outperform at Oppenheimer
02/05/21 B. Riley Securities
Quantum price target raised to $15 from $10 at B. Riley Securities
01/08/21 B. Riley Securities
Quantum price target raised to $10 from $9 at B. Riley Securities
QMCO Quantum
$7.54 /

+0.35 (+4.87%)

  • 04
    Feb
QMCO Quantum
$7.54 /

+0.35 (+4.87%)

Conference/Events
Alcon participates in a conference call with Morgan Stanley » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
ALC

Alcon

$70.43 /

+0.24 (+0.34%)

MedTech Analyst Furlong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$70.43 /

+0.24 (+0.34%)

ALC Alcon
$70.43 /

+0.24 (+0.34%)

05/07/21 JPMorgan
Alcon price target lowered to CHF 60 from CHF 61 at JPMorgan
05/06/21 Citi
Citi upgrades Alcon to Neutral on 'reasonable' guidance and 'fair' valuation
05/06/21 Citi
Alcon upgraded to Neutral from Sell at Citi
04/01/21 Berenberg
Alcon price target raised to CHF 80 from CHF 74 at Berenberg
ALC Alcon
$70.43 /

+0.24 (+0.34%)

Conference/Events
Harmonic to host virtual investor event » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
HLIT

Harmonic

$7.59 /

+0.01 (+0.13%)

Virtual Investor Event to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLIT Harmonic
$7.59 /

+0.01 (+0.13%)

HLIT Harmonic
$7.59 /

+0.01 (+0.13%)

06/01/21 Jefferies
Nearly 10% of ARPA funds going to broadband, says Jefferies
02/02/21 Stifel
Harmonic price target raised to $10 after 'strong results' at Stifel
01/14/21 Barclays
Harmonic price target raised to $8 from $7 at Barclays
09/23/20 Colliers
Harmonic opportunity in focus after SES partners with Microsoft, says Colliers
HLIT Harmonic
$7.59 /

+0.01 (+0.13%)

HLIT Harmonic
$7.59 /

+0.01 (+0.13%)

Conference/Events
Zebra Technologies participates in a conference call with Benchmark » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
ZBRA

Zebra Technologies

$508.07 /

+0.07 (+0.01%)

Analyst Harrigan holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBRA Zebra Technologies
$508.07 /

+0.07 (+0.01%)

ZBRA Zebra Technologies
$508.07 /

+0.07 (+0.01%)

04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Morgan Stanley
Zebra downgraded to Underweight from Equal Weight at Morgan Stanley
03/23/21 Northcoast
Zebra Technologies upgraded to Buy from Neutral at Northcoast
02/12/21 Needham
Zebra Technologies price target raised to $515 from $445 at Needham
ZBRA Zebra Technologies
$508.07 /

+0.07 (+0.01%)

ZBRA Zebra Technologies
$508.07 /

+0.07 (+0.01%)

ZBRA Zebra Technologies
$508.07 /

+0.07 (+0.01%)

Conference/Events
Stephens banking analysts to hold an analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Banking-East…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
SciPlay management to meet virtually with Truist » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
SCPL

SciPlay

$17.90 /

+0.04 (+0.22%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPL SciPlay
$17.90 /

+0.04 (+0.22%)

SCPL SciPlay
$17.90 /

+0.04 (+0.22%)

05/10/21 Wedbush
Wedbush still bullish on SciPlay after Q1 results, sees modest growth in 2021
03/02/21 Macquarie
SciPlay price target raised to $25 from $23 at Macquarie
02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
SCPL SciPlay
$17.90 /

+0.04 (+0.22%)

SCPL SciPlay
$17.90 /

+0.04 (+0.22%)

Conference/Events
Rent-A-Center participates in a conference call with Stephens » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
RCII

Rent-A-Center

$63.60 /

+1.89 (+3.06%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCII Rent-A-Center
$63.60 /

+1.89 (+3.06%)

RCII Rent-A-Center
$63.60 /

+1.89 (+3.06%)

05/03/21 Loop Capital
Rent-A-Center price target raised to $72 from $65 at Loop Capital
02/26/21 Raymond James
Rent-A-Center price target raised to $65 from $45 at Raymond James
02/26/21 KeyBanc
Rent-A-Center price target raised to $75 from $60 at KeyBanc
02/24/21 Stephens
Aaron's peers also potentially received California inquiry, says Stephens
RCII Rent-A-Center
$63.60 /

+1.89 (+3.06%)

RCII Rent-A-Center
$63.60 /

+1.89 (+3.06%)

Conference/Events
Ready Capital participates in a conference call with B. Riley » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
RC

Ready Capital

$15.73 /

+0.085 (+0.54%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RC Ready Capital
$15.73 /

+0.085 (+0.54%)

RC Ready Capital
$15.73 /

+0.085 (+0.54%)

05/28/21 B. Riley
Ready Capital price target raised to $17 from $16.50 at B. Riley
04/21/21 Keefe Bruyette
Ready Capital upgraded to Outperform from Market Perform at Keefe Bruyette
04/20/21 B. Riley
Ready Capital transferred with Buy, $16.50 target at B. Riley
03/12/21 BTIG
Ready Capital price target raised to $15.50 from $14 at BTIG
RC Ready Capital
$15.73 /

+0.085 (+0.54%)

Conference/Events
Inozyme management to meet virtually with Wedbush » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
INZY

Inozyme

$16.64 /

-1.61 (-8.82%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INZY Inozyme
$16.64 /

-1.61 (-8.82%)

INZY Inozyme
$16.64 /

-1.61 (-8.82%)

05/04/21 Piper Sandler
Inozyme should be bought up to $40 per share, says Piper Sandler
08/18/20
Fly Intel: Top five analyst initiations
08/18/20 Wedbush
Wedbush bullish on Inozyme, initiates with an Outperform
08/18/20 Wedbush
Inozyme initiated with an Outperform at Wedbush
INZY Inozyme
$16.64 /

-1.61 (-8.82%)

  • 24
    Jul
Conference/Events
Kymera Therapeutics participates in a conference call with UBS » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
KYMR

Kymera Therapeutics

$50.56 /

-1.41 (-2.71%)

Biotech Analyst Merle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$50.56 /

-1.41 (-2.71%)

KYMR Kymera Therapeutics
$50.56 /

-1.41 (-2.71%)

05/20/21 UBS
Kymera Therapeutics initiated with a Buy at UBS
04/14/21 Berenberg
Kymera Therapeutics initiated with a Buy at Berenberg
04/12/21 Piper Sandler
Piper would be buyer of Kymera Therapeutics amid pullback
03/02/21 Piper Sandler
Kymera Therapeutics plans to file two INDs in 2H21, says Piper Sandler
KYMR Kymera Therapeutics
$50.56 /

-1.41 (-2.71%)

  • 21
    Aug
KYMR Kymera Therapeutics
$50.56 /

-1.41 (-2.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.